# Antonio Costanzo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/antonio-costanzo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,448 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 66 |
| i10-index | 255 |
| Last Known Institution | Humanitas University |
| OpenAlex ID | https://openalex.org/A5053176930 |
| ORCID iD | 0000-0001-9697-2557 |
| Works | 570 |

## Researcher papers

Showing 12 of 13.

- [The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage](https://scholariq.org/papers/the-tyrosine-kinase-c-abl-regulates-p73-in-apoptotic-response-to-cisplatin/)
- [The p53/p63/p73 family of transcription factors: overlapping and distinct functions](https://scholariq.org/papers/the-p53-p63-p73-family-of-transcription-factors-overlapping-and-distinct/)
- [The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis](https://scholariq.org/papers/the-antimicrobial-peptide-ll37-is-a-t-cell-autoantigen-in-psoriasis/)
- [Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-upadacitinib-vs-dupilumab-in-adults-with-moderate-to/)
- [Activation of SAPK/JNK by TNF Receptor 1 Through a Noncytotoxic TRAF2-Dependent Pathway](https://scholariq.org/papers/activation-of-sapk-jnk-by-tnf-receptor-1-through-a-noncytotoxic-traf2-dependent/)
- [Splenic trauma: WSES classification and guidelines for adult and pediatric patients](https://scholariq.org/papers/splenic-trauma-wses-classification-and-guidelines-for-adult-and-pediatric/)
- [Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials](https://scholariq.org/papers/baricitinib-in-patients-with-moderate-to-severe-atopic-dermatitis-and-inadequate/)
- [Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity](https://scholariq.org/papers/two-new-p73-splice-variants-and-with-different-transcriptional-activity/)
- [DNA Damage-Dependent Acetylation of p73 Dictates the Selective Activation of Apoptotic Target Genes](https://scholariq.org/papers/dna-damage-dependent-acetylation-of-p73-dictates-the-selective-activation-of/)
- [Autoinflammatory and autoimmune conditions at the crossroad of COVID-19](https://scholariq.org/papers/autoinflammatory-and-autoimmune-conditions-at-the-crossroad-of-covid-19/)
- [Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis](https://scholariq.org/papers/italian-guidelines-on-the-systemic-treatments-of-moderate-to-severe-plaque/)
- [Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*](https://scholariq.org/papers/evidence-for-a-window-of-opportunity-in-hidradenitis-suppurativa-treated-with/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)

## Researcher university

- [Humanitas University](https://scholariq.org/institutions/humanitas-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
